These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35801596)

  • 1. Liquid biopsy as a tool for predicts of severe COVID-19 and hospitalised community-acquired pneumonia.
    Komarevtseva I; Ihnatova A; Rudenko I; Balabanova K; Komarevtsev V
    Pol Merkur Lekarski; 2022 Jun; 50(297):155-159. PubMed ID: 35801596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of neutrophil extracellular trap and its markers in the early diagnosis of community-acquired pneumonia in children].
    Chen D; Yang XL; Shen ZB; Sun XM; Guo Q; Ren YH; Zhang GC
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Sep; 21(9):868-875. PubMed ID: 31506144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood monocyte Toll-like receptor and serum surfactant protein A reveal a pathophysiological mechanism for community-acquired pneumonia in patients with type 2 diabetes.
    Que Y; Shen X
    Intern Med J; 2016 Feb; 46(2):213-9. PubMed ID: 26648341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.
    Andargie TE; Tsuji N; Seifuddin F; Jang MK; Yuen PS; Kong H; Tunc I; Singh K; Charya A; Wilkins K; Nathan S; Cox A; Pirooznia M; Star RA; Agbor-Enoh S
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33651717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretion.
    Hu Z; Chen H; Long Y; Li P; Gu Y
    Crit Rev Oncol Hematol; 2021 Jan; 157():103166. PubMed ID: 33254039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19.
    Barmanray RD; Cheuk N; Fourlanos S; Greenberg PB; Colman PG; Worth LJ
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35790320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
    Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
    Front Immunol; 2021; 12():714026. PubMed ID: 34745092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fragmentomic property of plasma cell-free DNA enables the non-invasive detection of diabetic nephropathy in patients with diabetes mellitus.
    Yu C; Lin Y; Luo Y; Guo Y; Ye Z; Ou R; Zhang Y; Wang X; Qu R; Zhou W; Li J; Bai Y; Yu X; Zhang H; Yan L; Jin X
    Front Endocrinol (Lausanne); 2023; 14():1164822. PubMed ID: 37867508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
    Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
    Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
    Yu Z; Qin S; Wang H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study.
    Hoeter K; Neuberger E; Fischer S; Herbst M; Juškevičiūtė E; Enders K; Rossmann H; Sprinzl MF; Simon P; Bodenstein M; Schaefer M
    PeerJ; 2023; 11():e16072. PubMed ID: 37744227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction of in-hospital mortality among patients with type 2 diabetes mellitus and concomitant community-acquired pneumonia.
    Cheng S; Hou G; Liu Z; Lu Y; Liang S; Cang L; Zhang X; Zou C; Kang J; Chen Y
    Ann Palliat Med; 2020 Sep; 9(5):3313-3325. PubMed ID: 32921127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes.
    Bello S; Lasierra AB; López-Vergara L; de Diego C; Torralba L; de Gopegui PR; Lahoz R; Abadía C; Godino J; Cebollada A; Jimeno B; Bello C; Tejada A; Torres A
    Respir Res; 2023 May; 24(1):125. PubMed ID: 37147677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic potential of circulating cell-free microRNAs for community-acquired pneumonia and pneumonia-related sepsis.
    Hermann S; Brandes F; Kirchner B; Buschmann D; Borrmann M; Klein M; Kotschote S; Bonin M; Reithmair M; Kaufmann I; Schelling G; Pfaffl MW
    J Cell Mol Med; 2020 Oct; 24(20):12054-12064. PubMed ID: 32916773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.